Meanwhile, over-expression of THY1 also predicted poor (DFS) in esophageal carcinoma, kidney renal papillary cell carcinoma, prostate adenocarcinoma, skin cutaneous melanoma, and uveal melanoma (Figure 2Q and Supplementary Figure 2). Here, THY1 is linked to prostate adenocarcinoma.